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"roe!! activation in the absence of co-stimulatory signals can lead to 
m,iuc:'~m of anerg3'. Professional antigen-presenting cells (APCs) of bone 
marrw~ origin, such as macrophages and dendritic cells, can provide co- 
~:: mlati, m through molecules such as B7-1 and B7-2. In addition, cells of 
epzthelia! , .,gin c,m fimction as "non-professional' APCs when activated. 
;,z t!:ese circumstances, the functional consequences of the T cell-APC inter- 
action may differ, perhaps due to the nature of the co-stimulatory path- 
u,avs utilized and~or the cytokines encountered by the T cell. Here, Brian 
"~ickoloff and Laurence Turka sugges~ that these differences may be 
important in regulating immune responses to local 
antigens and also in maintaining self-tolerance. 
Research accumulated over the past several years has 
demonstrated convincingly that resting T cells require 
at least two signals for induction of cytokine gene 
expression and cell proliferation (reviewed in Refs 1 
and 2). Signal 1 can be produced by ligation of the 
T-cell receptor(TCRJ/CD3 complex with antigenic 
peptides bound to tile appropriate major histocornpati- 
bilitv complex (MHC) moleo,!,:. Altho,i~;h signal 1 can 
also be delivered by stimulat-~rv antibodies directed at 
non-polymorphic portions of the TCR/CD3 complex, 
it is envisaged that, in physiological situations, signal 1 
provides antigen specifici~. By contrast, signal 2, often 
termed the 'co-stimulatory" signal, is not antigen 
specific and was originally defined as an activity pro- 
vided by bone-marrow-derived accessory cells such as 
macrophages or dendritic cells, although activated 
B cells were also found to be capable of providing co- 
stimulation. Each of these cells also bears MHC class II 
molecules and has the capacity to present antigen to 
CD4- T cells. The terms 'professional' antigen-presenting 
cells (APCsl or 'accessory" cells have been coined to 
describe the population of bone-marrow-derived cells 
that possess this capability. 
The nature of the co-stimulatorv signals provided by 
professional APCs has been the subject of intense 
scrutiny Although T helper 2 (Th2)-cell clones can 
release soluble mediators such as interleukin 1 (IL-I) 
that may provide signal 2, in most instances it appears 
that co-stimulatory signals are provided by surface 
molecules on APCs interacting with their cognate li- 
gands on T cells I-4. Several molecules have been pro- 
visionally shown to W~ssess co-stimulatory capacity, 
including heat stable antigen (HSA) (Ref. 5), invariant 
chain modified by chondroitin sulfate (Ii-CS) (Ref.6) 
and perhaps intercellular adhesion molecule 1 (ICAM-1) 
(Ref. 7). However, the co-stimulatory pathway that has 
received the most attention to date is that mediated via 
the interaction of CD28 on T cells with one of its li- 
gands, B7-1 or B7-2/B70, on professional APCs (Ref. 8). 
Stimulation of CD28 in this manner leads to induction 
and enhancement of lymphokine gene expression, a 
process mediated by intrace!!u!ar signals distinct from 
tho¢.: transduced through the TCR/CD3 complex 9. 
CTLA-4, a gene related to CD28, is expressed on T cells 
and is also a ligand for B7-1 and B7-2/B70 (Ref. 10), 
although the nature of the signal transduced by CTLA-4 
remains unknown tl 
Co-stimulation by no~-l:;,ofesslonal APCs 
MHC class II molecules are usually expressed pri- 
marily on profession:~! APCs (Ref. i2). However, fol- 
lowing cytokine stimulation in vitro, or during inflam- 
matory states in vivo, MHC class II molecules are 
induced on a wide variety of epithelial and endothelial 
cells. Thus, provision of co-stimulatory signals could 
enable these cells to initiate immune responses in the 
absence of professional APCs. Experiments using 
human keratinocytes as an epithelial cell model have 
provided interesting results in this context t3,t4 {Fig. 1). 
These multi-passaged keratinocytes are prepared from 
skin biopsies of healthy individuals, and are completely 
depleted of Langerhans cells (dendritic cells of bone 
marrow origin that normally reside in the epidermal 
layer of skin) by multiple passages in tissue culture. 
Keratinocytes in vitro and in vivo do not express MHC 
class II antigens constitutively, but can be induced to 
do so after exposure to interferon ~/(IFN-'y). Following 
activation, MHC class II-expressing keratinocyt~ are 
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able to provide co-stimulatory signals to T cells that have 
been rigorously n~:.ri."~ed. These signals are sufficient to 
support "l-,:cli pr,~iite~arinn following stimulation with 
bacteria-derived supciantigens (SAgs) such as staphylo- 
coccal enterotoxln A (SEA) or SEB, phytohemagglutinin 
(PHA), or anti-CD3 monoclonal antibody (mAb). Thus, 
MHC class II + epithelial non-professional APCs are 
able to function as accessory cells in providing requisite 
signals for T-cell proliferation (Fig. 1). Similar results 
have been demonstrated for endothelial cells Ls. 
The finding that keratinocytes can provide co-stimu- 
latory signals prompted a search to identify the rel- 
evant pathway by which this occurs. An obvious 
candidate was B7, now recognized to be a family of 
molecules that includes two cloned genes, B7-1 and 
B7-2/B70 (Refs 16,17). These studies led to the interest- 
ing observation that an anti-B7 mAb (now known 
to recognize BT-1) and anti-BB-1 mAb had disparate 
patterns of reactivity on keratinocytes. Thus, keratin- 
ocytes bound anti-BB-1 mAb but did not react with 
anti-B7-1 mAb, nor with a CTLA-4-Ig fusion protein 
that binds both to B7-1 and B7-2 (Ref. 13). The epitope 
recognized by anti-BB-1 mAb (subsequently termed 
B7-3) appeared to be a ligand for CD28, based on 
adhesion studies with CD28 transfectants. However, 
blocking this interaction with 0nti-BB-1 mAb does not in- 
hibit keratinocyte-mediated co-stimulation. This suggests 
that this CD28 ligand might not be mediating co- 
stimulation in this instance, particularly as anti-BB-1 mAb 
is an effective inhibitor of CD28-dependent co-stimulation 
in other systems ~4. On testing a large panel of mAbs, only 
anti-MHC class II mAbs, and mAbs directed against 
either lymphocyte function-associated molecule 1 (LFA-1) 
or ICAM-1, blocked proliferation. In the former case, 
it can be assumed that inhibition of proliferation is due 
to prevention of the delivery of signal 1. In the latter 
case, considerable controversy exists as to whether or not 
LFA-1 transduces a co-stimulatory signal. When defined 
as augmentation of proliferation, LFA-l-mediated signals 
are clearly co-stimulatory v. However, when a more-strict 
definition is used, in which co-stimulation must be 
active both in cis and in trans, many investigators do 
not demonstrate co-stimulatory activity through this 
pathway 18. This is also supported by the finding that 
stimulation through CD28 resulted in the transduction 
of intracellular signals that are distinct from those 
elicited by the TCR, whereas LFA-l-mediated signals 
appear to be qualitatively identicaP 9,-'°. Furthermore, 
the effect of LFA-1 on proliferation is not necessarily 
accompanied by co-stimulation of IL-2 production 
or the ability to prevent induction of anergy 2~. Thos, 
we favor the interpretation that, in this system, co- 
stimulatory signals for activated T cells are not being 
delivered through B7-3-CD28 (based on the inability 
of anti-BB-1 mAb to block proliferation) or through 
LFA-1. Instead, alternative co-stimulatory structures 
are likely to be involved, and the roles of HSA (Ref. 5) 
and Ii-CS (Ref. 6) are currently under investigation. 
The APC type may influence the cytokines produced 
from resting T cells 
Resting T cells have the potential to produce a 













Fig. 1. Accessoo, fimction of professional and non-professional antigen-pre- 
senting cells (APCs) such as (a) dendritic cells (DCs) and (b) epitbelial cells 
(ECs), respectively Bone-nlarrow-derived professional APCs, as well as non- 
hematopoietic ECs, can provide co-stinlulatory signals to T cells stimulated 
with superantigen (SAg) via interaction between tbe major histocompatibilio, 
complex (MHC) and the T-cell receptor (TCR). This leads to T-cell prolifer- 
ation and cytokine production. (a) In the case of professional APCs, the co- 
stimulatory signals can be delivered when B7 (both B7-I and B7-2) binds to 
CD28. Other, as yet uncharacterized, co-stimulatoo, pathu,ays may also be 
invoh,ed. (b) ECs express neither B7-1 nor B7-2 and deliver their co-stimu- 
latorv signals through unknown cell-surface or soluble proteins. Althougb 
ECs nlay express the CD28 ligand B7-3 (BB-I), it is to.clear ira CD28-B7-3 
interaction provides T-cell co-stimu!ation~ SAgs are sh~;u,n here as the T-cell 
stimuhts since many ECs do not process proteins into nominal antigens, nor 
do they stimulate allogeneic T cells (see Fig. 2 and accompanying text). 
IFN-3', IL-4, IL-5 and IL-10 (reviewed in Ref. 22). 
According to one popular theory, these so-called Th0 
cells have not yet differentiated into a discrete profile 
of cytokine production, but do so following continued 
stimulation. The differentiation into Thl versus Th2 
cells is thought to be related primarily to the milieu in 
which the T cells undergo stimulation, and especially 
to the cytokines present in the local environment. 
However, apart from the cytokines the APCs might 
themselves produce, little is known regarding the 
potential influence of APCs on this event. Interestingly, 
whereas co-stimulation via CD28 is known to enhance 
strongly the T-cell production of various cytokines, at 
least two groups have shown that blockade of this 
pathway skews T cells towards IL-4 production -'3"24. 
This suggests that another co-stimulatory pathway 
may also be available for IL-4 production by naive T 
cells or by committed Th2-type IL-4-producing cells. 
Given the fact that non-professional APCs (exemplified 
in this case by keiatinocytes) can provide effective co- 
stimulation for T-cell proliferation, and that co-stimu- 
lation does not appear t,-, be delivered through the 
CD28-B7 pathway, the question arose as to whether 
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Fig. 2. immrimt d3m (Ii)-aegative cells da not stimkate allogeneic T cells. 
One possibk esphwtion for the inabili? of major histocotnpatibilit?, com- 
pkx ~MHCI class II‘ keratinoq’tP_c to stmrlate alloreactive T cells is their 
fahre to express normal levels of li in the otophsm and at the cell surface. 
Ii is bnouw to aJiect the co?tfonnation andlor peptide-binding ability of 
MHC chs II molecules. (a) T cells bind and respond to allogeneic MHC 
cl&-s II antigens expressed on the srrrface of li- antigen-presenting cells 
(APCs) SUC-13 JS dendritic cells (DCs). lb) In the c;bsence of normal levels of li 
in epithehl cells [ECs). MHC chss II molecdes dre expressed in an altered 
conformation (depicted here) andlor with defective peptide binding. These 
‘altered’ MHC molecules mq not be capable of stimrlating allogeneic T cells 
via the T-cell receptor (TCRI, or there may be a markedly decreased 
fieqnenq of possible T-cell responders. (cl),(d) By contrast, slrperantigens 
,qr\oc) &.J ,.~.,.Il,, .JL4~..‘J.. ‘- ldur -I--- ” 
,_. ‘_” I?..... ‘y”“,‘, C,,CCUL CC) LV 1~11 I L L his I I moiecuies 
from II- md Ii- cells. respectively 
non-professional APCs might lead to a different 
cytokine profile of stimulated T cells than that seen 
with professional APCs. Experiments performed to 
examine this issue showed that, when monocytes were 
used as accessory cells, a ThO profile of cytokines 
(IL-L, IFN-y, IL-4) was produced”. By contrast, when 
keratinocytes were used as accessory cells, there was a 
specific defect in IFN-y production by T cells, while IL-2 
and IL-4 responses were intact. Surprisingly however, 
provision of CD28 activation with a stimulatory anti- 
CD28 mAb, although augmenting IL-2 production in 
keratinncyte-supported cultures, did not correct the 
defect in IFN--y expression. Mixing experiments 
demonstrated that keratinocytes could not inhibit the 
ability of professional APCs to induce IFN-y pro- 
duction. Together, these data suggest that failure of 
keratinocytes to induce T-cell production of IFN-y was 
not due to ‘suppression’ or to a lack of productive 
CD28 stimulation. 
Recent work has demonstrated that a key switch 
that induces ThO cells to become Thl cells is the 
cytokine IL-12 (Ref. 26). IL-12 is known to be pro- 
duced by macrophages and activated B cells, and to 
exert an effect directly on T cells. Although IL-12 does 
not appear to be dbsohitely necessary to prime cells for 
IFN-y production (particularly if IL-2 is present), it 
greatly augments the amount of IFN-y produced when 
compared with cells stimulated in its absence2’. The 
ability of IL-12 to prime cells for IFN-y production is 
observed even in the presence of IL-4. 
Bioactive IL-12 protein comprises two chains of 
molecular weights 35 kDa and 40 kDa. The 35 kDa 
chain is constitutively expressed in many cells and is 
not influenced by cell activation. By contrast, the 
40 kDa chain is much more restricted, being expressed 
in only limited cell types (e.g. professional APCs) and 
only then after activation. Thus, expression of the 
40 kDa chain is ultimately believed to regulate pro- 
duction of the mature protein heterodimer. When 
keratinocytes were examined by reverse transcriptase 
polymerase chain reaction (RT-PCR), they were found 
to express constitutive levels of the 35 kDa chain that 
were comparable with those observed in peripherai 
blood mononuc!ear cells (PBMCs) (Ref. 25). However, 
the inducible 40 kL”a chain was barely detectable in 
keratinocytes either at rest or following a variety of 
stimuli, including phorbol ester, tumor necrosis factor 
(TNF-a) and IFN-y. Thus, when T cells were stimu- 
lated with SAg in the presence of keratinocytes, the 
40 kDa chain dr IL-12 was present at less than 
l/lOOOth the level of that observed when T cells were 
similarly stimulated in the presence of professional 
APCs. Despite this, the overall levels of proliferation and 
IL-2 production were comparable in both cases. More- 
over, when recombinant IL-12 was added to cultures in 
which keratinocytes were used as accessory cells, two- 
to tenfold increments in IFN-y were observed. Together, 
these data support the concept that the relative lack of 
IFN-y production seen in keratinocyte-supported cul- 
___ 3 tures was due to the fai!ure of these cells to proauce 
IL-12. 
Mechanisms by which APCs can determine cytokine 
production 
There are at least two possible mechanisms by 
which ,2PCs can influence the pattern of cytokines 
produced by T cells, and these are not mutually ex- 
clusive. First, and most-directly supported by the data 
cited above, cytokines produced by the accessory cells 
providing co-stimulatory signals may be important in 
dictating the cytokines produced by the T cells. For 
example, IL-12 greatly augments IFN-y production, 
whereas IL-10 tends to block it. Professional APCs 
and epithelial cells differ in that only the former 
appear to produce IL-12. By contrast, some non- 
professional APCs can secrete IL-10 (Ref. 28). Other 
soluble mediators such as transforming growth factor 
B (TGF-B) and prostaglandin Ez (PGEJ, produced to 
varying degrees by cells capable of delivering co-stimu- 
latory signals, might also be capable of influencing not 
only the quantity of T-cell-derived lymphokines pro- 
duced, but also the overall balance amongst various 
lymphokines. 
As mentioned above, a second mechanism by which 
APCs might dictate qualitative differences in the 
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production of T-cell cytokines is through the type of 
co-stimulatory signal delivered. Activation of CD28 is 
by far the best understood co-stimulatory pathway. 
However, the newly discovered existence of multiple 
CD28 ligands 16.1v, and the potential influence of signals 
delivered through the highly homologous CTLA-4 
molecule, leave open the possibility that each ligand or 
pathway might have selective effects on the production 
of cytokines by T cells. The cytokines induced by other 
co-stimulatory pathways (e.g. HSA or Ii-CS) have not 
been studied to a significant extent. 
Epithelial cells may not 'present' alloantigen 
In several different systems, a variety of investigators 
have noted that non-professional APCs are poor stimu- 
lators of alloreactive T cells in mixed lymphocyte- 
epithelial-cell reactions. This is often attributed to the 
inability of epithelial cells to provide co-stimulation. 
However, as shown above for the case of SAgs, kera- 
tinocytes can provide signal 2, yet these same MHC 
class II-expressing cells fail to induce proliferation of 
allogeneic T ceils. One potential explanation is that 
11 " c' cells require a a o-stamulate : T co-stimulatory signal 
distinct from the one provided by keratinocytes. For 
example, in vivo studies have suggested that alloreac- 
tions are exquisitely dependent on the interaction of 
CD28/CTLA-4 with B7-1 or B7-2 (reviewed in Ref. 8). 
However, even when productive CD28 engagement is 
provided by a stimulatory mAb, allogeneic T cells fail 
to proliferate (Ref. 14; L.A. Turka et al., unpublished). 
Similarly, only a weak response is observed when a 
keratinocyte cell line is transfected with B7-1 (Ref. 29; 
B.J. Nickoloff et al., unpublished). 
An alternative explanation is that the nature of the 
peptide-MHC class II complex on keratinocytes differs 
from that on professional APCs (Fig. 2). Several lines 
of evidence support this hypothesis. First, in pro- 
£ _  • ! A I t , w - ,  tesslonal ~r~s,  the non-polymorphic class ii-associated 
Ii is intimately involved in processing, transport and 
peptide presentation of MHC class II molecules 3°. 
Second, in the absence of Ii, protein antigens are poorly 
presented: MHC class II molecules made in cells lack- 
ing Ii have distinct conformational 'abnormalities', as 
demonstrated by different reactivities with anti-MHC 
class II mAbs (Ref. 31). Finally, murine intestinal epi- 
thelial cells 31 and human keratinocytes 32 both lack or 
express only low levels of Ii, and neither cell type stimu- 
lates allogeneic T cells. In the latter instance, a low 
level of proliferation is observed if professional APCs 
autologous to the T cells are added, most likely a result 
of indirect presentation of alloantigen. This hypothesis 
predicts that SAgs are capable of binding to MHC 
class II molecules synthesized in Ii-deficient cell types. 
Consistent with this, Ii-knockout mice are capable of 
negative selection of self-SAg-reactive T cells 33. A testable 
prediction of this hypothesis is that transfection of Ii 
into keratinocytes would reconstitute their ability to 
stimulate allogeneic T cells. 
The epithelial environment 
Naturally, there are professional APCs within 
epithelial surfaces. Clearly, one has to take into 
account the functional contribution of all potential 
Original ideas 
Epithelial cells bearing MHC 
class I antigens are passive 
targets for T cells. 
Box 1. Epithelial cells in immune responses 
Extended concepts 
Epithelial cells can be active 
initiators of immune re- 
sponses, providing co-stimu- 
latory signals to resting T 
cells. Lack of alloreactivity 
could be due to intrinsic dif- 
ferences in MHC class II mol- 
ecules (e.g. diminished in- 
variant chain) rather than 
from lack of co-stimulatory 
capacity. 
CD28/CTLA-4 ligands are 
restricted to hematopoietic 
cells. 
Epithelial cells express BB-1/ 
B7-3, an additional CD28/ 
CTLA-4 counter-receptor. 
The effects of CD28-BB-1 
engagement are unknown. 
The determinants of whether 
stimulated T cells differen- 
tiate into Thl or Th2 cells 
include the duration of stimu- 
lation, the nature of the anti- 
gen, the cytokine milieu and 
the genetic background of 
the animal. 
The nature of the APC, pro- 
fessional versus non-pro- 
fessional, may play a role in 
determining whether T cells 
become Th I or Th2 cells. 
T-cell anergy following inter- 
actions with epithelial cells is 
the result of failure to receive 
a second signal. 
Epithelial cells may induce ef- 
fective Th2 responses. The ab- 
sence of a cell-mediated (Thl) 
response can appear as anergy 
depending on the assay used. 
Abbreviations: MHC, major histocompatibility complex; Thl, T 
helper 1; APC, antigen-presenting cell. 
APC-T-cell interactions to appreciate fully the 'net' 
immunological outcome. It is not tF.'~ intention of this 
article to minimize the importance of professional 
APCs but to point out that, by their sheer number, 
epithelial cells such as keratinocytes should not be 
neglected from consideration. In some instances, exter- 
nal factors may push the immunological balance 
further towards an epithelial cell 'sphere of influence'. 
For example, exposure of skin to ultraviolet light leads 
to a loss of Langerhans cells in the epithelial layer, arid 
induces keratinocytes to produce IL-10 (Ref. 34). 
Thus, the resulting environment is one in which epi- 
thelial cells may drive or predominate in the initial 
immune response. Even when professional APCs sub- 
sequently remigrate into the epithelium, they will 
encounter T cells that have been stimulated and have 
begun to differentiate under 'epithelial-dominant' con- 
ditions. It will be important to determine if these T 
cells are irrevocably committed to production of Th2 
cytokines, or if this pattern can be subsequently 
reversed. 
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Perceived as anergy if tested 
for Thl -effector functions 
Fig. ~. Var3.'ing consequences o( antigen e,zcounter. Resting T cells, so-called 
T belper 0 cTbOl cells, require at h'ast tu',~ sko, n,lls for induction of cell prolif- 
eratum and the expression of O,tokme gem's. Stmmlation of the T-cell recep- 
tor ITCRi provides szgnal I and. in the absence of a second s(~lal. T-cell 
aner,o 3" tot perhaps deatbl ensues. Delivery of signal 2 by a professional anti- 
gen-presentmg cell IAPC) is fi)lhm,ed by chmal expansion in a manner and 
enl,ironment that favors different.ation into Th l effectors. Com'ersel3; u,hen 
sl~zal 2 is delivered by a ram-professional APC, such as an epithelial cell (EC), 
the process favors differentiation into Th2 effectors. If assays of T-cell func- 
tion art" used that depend on the detection of mterleukm 2 IIL-2) or interferon 
¢IFN-30 production, or Th l-dependent responses, then this process may be 
perceived as aner,o 3' when, m fact, a specific immune 
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Conclusions and implications 
Much recent work has extended our understanding 
of the immune functions of non-hemaropoietic cells 
that are not usually thought of as professi real mem- 
bers of the immune system. Endothelial cells are a well- 
studied example of this, and increasing data indicate 
that these cells may function as immunocytes. Box 1 
outlines some original ideas regarding epithelial cells, 
and proposes extended concepts based on recent studies. 
One implication of these ideas (Fig. 3) is that, when 
epithelial t.ells induce active T-cell immune responses 
of the Th2 type, this can either be mistaken for anergy 
in vitro (if assays of Thl function are only examined) 
or be functionally equivalent to anergy in vivo (if the 
immune response readout requires Thl function) ~s. 
Recent work by Gajewski et al. ~ provides support for 
this concept, demonstrating that 'anergized' Th0 clones 
may give rise to Th2 cells. In this manner, epithelial 
cells can regulate the nature of the immune response to 
local antigens. For example, in the case of skin, failure 
of keratinocyte-supported responses to induce IFN-~, in 
T cells, resv!ting in the the generation of Th2 cytokines, 
may play a role in peripheral tolerance to self antigens~ 
the induction of IgE-mediated allergic responses (e.g. 
atopic dermatitis) and the termination of cell-mediated 
immune r'~actio~as (e.g. the challenge phase of allergic 
contact dermatitis). Disruption of this cytokine balance 
may be important in autoimmune states such as pso- 
riasis. Converseb; deliberate exploitation of epithelial 
cells to induce a Th2 response may be effective in 
inducing transplantation tolerance, and suggests that 
keratinocytes could be useful cells for gone transfer 
techniques. 
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The suitability of human chorionic 
gonadotropin (hCG)-based 
birth-control vaccines 
Stephan Dirnhofer, Georg Wick and 
Peter Berger 
It has been widely hoped that immunological methods of fertility regu- 
lation by active immunization against specific antigens of the oocyte, sperm, 
zygote and early embryo, and the placental pregnancy hormone human 
chorionic gonadotropin (hCG), will provide a means to contro~ the prob- 
lem of worldwide population growth. The most advanced candidate vac- 
cines are based on hCG immunogens and have entered clinical trials. 
However, during the past few years, increasing evidence has emerged that 
the current approaches using hCG as the target molecule may have some 
major drawbacks. On the basis of their recent findings, Stephan Dirnhofer 
and colleagues raise doubts on the suitability, safety and efficacy of 
gonadotropin-based immunological contraceptive vaccines 
The control of worldwide population growth is with- 
out doubt one of the most urgent problems of 
mankind. Global population continues to increase on 
a hyperexponential scale previously unrecorded in 
human histor), with the result that over 6200 million 
people will populate our planet by the year 2000. Thus, 
new and improved methods of fertility regulation are 
urgently needed and represent a socially compelling 
and scientifically challenging issue. 
In the past years, substantial progress has been made 
ill unravelling the complcx interactions between the 
immune system and the reproductive system, and a 
number of possibilities for immunological contraception 
have emerged v6. The rationale underlying research 
endeavours has been the development of new methods 
of family planning that provide safe, effective and 
long-lasting contraception from a single administration 
that is reversible, inexpensive, practical to use and gen- 
erally acceptable. The most promising approach uses 
antifertility vaccines based on, and directed against, 
molecules essential for the reproductive process. 
Candidate antigens include those of the sperm mem- 
brane, zona pellucida, trophoblast membrane and prod- 
ucts, as well as hormones involved in reproductive 
physiology and, amongst these, human chorionic 
gonadotropin (hCG) is the forerunner ~-9. 
Vaccines against hCG 
The hCG hormone is a member of the human (h) 
glycoprotein hormone family, whose members show 
close evolutionary, immunological and biochemical 
similarity. The family also includes luteinizing hor- 
mone (LH), follicle-stimt:lating hormone fiSH) and 
thyroid-stimulating hormone (TSH). All four hormones 
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hnmu,,ology Today 469 Vol. 15 No. 10 1994 
